NAPS Consortium

The NAPS Study seeks to improve the quality of life and care of individuals living with RBD through clinical care, research and education.

[NAPS Consortium @NapsConsortium]

Thank you for following us on X!

Starting in 2025, we’re focusing all our energy on two platforms.

Come join the conversation—see you on Facebook and LinkedIn!

Facebook: https://t.co/gZckp08Brt
LinkedIn: https://t.co/F944FemqZ5
Website: https://t.co/YFqwoutrs9

[NAPS Consortium @NapsConsortium]

As we wrap up another year, we look back on the progress we’ve made in learning more about RBD.

From our entire team to you, thank you for being a part of our journey. We look forward to an exciting 2025 ahead!

https://t.co/WV3TjNgdpx

[NAPS Consortium @NapsConsortium]

New research links REM Sleep Behavior Disorder (RBD) to Parkinson’s. Scientists found neuron subtypes that trigger REM sleep and RBD-like states. Abnormal synuclein in these cells could lead to new treatments.

Read more: https://t.co/rEoiBw874u

[NAPS Consortium @NapsConsortium]

🚨 Clonazepam Recall Alert 🚨

The product cartons show incorrect strength info, potentially leading to serious side effects. Many individuals with RBD take clonazepam (brand name Klonopin) to control their symptoms.

[U.S. FDA Recalls @FDArecalls]

Endo Expands Voluntary Recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) Due to Potential Product Carton Strength Mislabeling https://t.co/6oqclPQZOT

[U.S. FDA Recalls @FDArecalls]

Endo Expands Voluntary Recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) Due to Potential Product Carton Strength Mislabeling https://t.co/6oqclPQZOT

[NAPS Consortium @NapsConsortium]

RBD Question of the Week❓���💡
⎯
This week, we have Drs. Roneil Malkani from Northwestern University and Ron Postuma from McGill University to answer one of our most pressing RBD questions.

[NAPS Consortium @NapsConsortium]

The NAPS Investigator Meeting started today in LA, with updates on data from 527 participants who’ve completed 1134 visits! Huge thanks to our participants for their time and effort in supporting crucial research on neurodegenerative diseases. #NAPS #NeurodegenerativeResearch

[NAPS Consortium @NapsConsortium]

A recent study links poor sleep quality to accelerated brain aging. Experts stress that prioritizing good sleep is vital for cognitive health, suggesting that better sleep may reduce the risk of cognitive decline and neurodegenerative diseases.

https://t.co/dpK5Bja5cN

[NAPS Consortium @NapsConsortium]

RBD Question of the Week❓💤💡
⎯
This week, we have Drs. Roneil Malkani from Northwestern University and Ron Postuma from McGill University to answer one of our most pressing RBD questions.

[NAPS Consortium @NapsConsortium]

Memory loss is common in Alzheimer’s, but other signs like waking at 3 a.m. or daytime sleepiness may signal dementia types like Lewy bodies or Parkinson’s.

Learn more: https://t.co/dw9Q4fWqRF

[NAPS Consortium @NapsConsortium]

We're making strides in neurodegenerative disease research! 💡🔬🧠

We just finished our second Industry Roundtable at the Movement Disorders Society Congress, focusing on advancing clinical trials for neuroprotective treatments targeting synucleinopathies.

[NAPS Consortium @NapsConsortium]

A Dutch study found no link between long-term benzodiazepine use and dementia in healthy older adults. However, benzodiazepines were tied to reduced brain volume in areas like the hippocampus and amygdala. 🧠📉 Learn more: https://t.co/jYH9jUwKlw

[NAPS Consortium @NapsConsortium]

37% of adults tried viral sleep trends in 2024, says @AASMorg. Experts warn trends like "bed rotting" & magnesium drinks can harm health. Stick to proven tips like consistent schedules & consulting a doctor.

💤 Read more: https://t.co/x2HOj0qF6T

[NAPS Consortium @NapsConsortium]

Wearable tech may help track non-motor Parkinson’s symptoms like sleep issues linked to REM sleep behavior disorder. NAPS will soon begin a pilot study at select sites.

Read more on recent findings: https://t.co/yIzBjt3M9s

[NAPS Consortium @NapsConsortium]

Can a stroke affect sleep? A new study in Neurology found stroke survivors were 50% more likely to sleep excessively or too little compared to those without a stroke history.

Learn more: https://t.co/Feyct9BfAI

[NAPS Consortium @NapsConsortium]

RBD Question of the Week❓💤💡
⎯
This week, we have Dr. Carlos Schenck, a physician who first described RBD and a member of the NAPS Scientific Advisory Board, to answer one of our most pressing RBD questions.

[NAPS Consortium @NapsConsortium]

A study suggests voice analysis in RBD patients may help detect early Parkinson’s progression. AI monitoring of voice, movement, and walking patterns shows promise but needs further validation.

👂Read the full abstract to learn more: https://t.co/hgOWZA5PoE

[NAPS Consortium @NapsConsortium]

@nytimes delves into the rise of sleep optimization, noting the risks of 'orthosomnia'—an excessive focus on perfect sleep that can backfire. While aids like magnesium and gadgets help some, experts emphasize simpler habits.

💤 Learn more: https://t.co/n0mzdtYZQo

[NAPS Consortium @NapsConsortium]

RBD Question of the Week❓💤💡
⎯
This week, we have Dr. Carlos Schenck, a physician who first described RBD and a member of the NAPS Scientific Advisory Board, to answer one of our most pressing RBD questions.

[NAPS Consortium @NapsConsortium]

A study by Dr. Michael Howell and NAPS team at @UMNews found key differences between RBD triggered by antidepressants (Serotonergic RBD) and idiopathic RBD (iRBD). Follow-up ongoing to assess neurodegenerative risks.

💊 Learn more: https://t.co/V2nWP3xHiM